• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Characterization of the Anti-Cancer Activities of Clinical Candidate Galeterone (VN/124-1) and its Novel Analogs in Human Prostate and Pancreatic Cancer Models In Vitro and In Vivo

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    KWEGYIRAFFUL_umaryland_0373D_1 ...
    Size:
    29.65Mb
    Format:
    PDF
    Download
    Author
    Kwegyir-Afful, Andrew Kenneth
    0000-0002-6852-0972
    Advisor
    Njar, Vincent
    Date
    2016
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Cancer is a "moving target" disease, as the condition progresses, critical driving oncogenes evolve. Effective treatment for cancers, such as prostate cancer (PC) and pancreatic ductal adenocarcinoma (PDAC) are based on targeting multiple oncogenes implicated in disease progression and drug resistance. Our group pioneered the development of galeterone (gal, originally designated VN/124-1); a small molecule inhibitor that impedes both AR positive and negative tumor growth, suggesting its ability to modulate multiple oncogenes. The goal of this thesis was to assess the ability of gal and novel analogs to modulate multiple oncogenic targets in a variety of clinically relevant human PC and PDAC models to inhibit cell viability, tumor growth and metastatic potential. Our studies show that gal and VNPT55 induce proteasomal degradation of AR/AR-V7, implicating Mdm2/CHIP E3 ligase. Gal/VNPT55 also degraded ARv567es, with VNPT55 exhibiting additional effects on AR-V7 mRNA. We also observed significant gal/VNPT55-induced increase in Bax/Bcl-2 ratio preceding cytochrome c release with a concomitant cleavage of caspase 3 and PARP, culminating in apoptosis. Gal and analogs also repressed pathways implicated in invasiveness (NF-KB, Twist1 and Mnk1/2-eIF4E axis), depleted expression of epithelial-mesenchymal-transition markers (N-Cadherin, MMP-2/-9 and Snail) and down-regulated putative stem cell factors (CD44, Oct-4 and BMI-1). These effects resulted in inhibition of cellular biological activities (migration and invasion) in vitro. Furthermore, gal/analogs effectively decreased viability of several drug-resistant PC cells. Strong anti-proliferative activity on gal-resistant cells by the novel analogs unraveled the lack of cross resistance. Additionally, anti-tumor activity of gal and VNPT55 on CWR22Rv1 xenograft (CRPC model) recapitulated in vitro activities of the compounds, with no apparent host toxicity. Finally, based on the findings that these agents effectively inhibited pathways associated with PDAC disease progression and drug-resistance, we assessed the potential of the agents as PDAC therapy. Gal/analogs alone or in combination with gemcitabine significantly decreased viability of gemcitabine-naive/resistant PDAC cells. Gal/analogs also inhibited transcription factors, prominent in PDAC disease progression. These agents also caused strong growth inhibition of MiaPaCa-2 xenografts. Together, these data demonstrate that gal and novel analogs possess multiple anti-cancer properties, providing a strong rationale for their development in prostate and pancreatic cancer therapy.
    Description
    University of Maryland, Baltimore. Toxicology. Ph.D. 2016
    Keyword
    cancer biology
    drug combination strategies
    drug discovery and development
    drug toxicity
    Prostate--Cancer--Treatment
    Pancreas--Cancer--Treatment
    Drug-Related Side Effects and Adverse Reactions
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/5449
    Collections
    Theses and Dissertations School of Medicine
    Theses and Dissertations All Schools

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.